Trials / Conditions / Myasthenia Gravis (MG)

Myasthenia Gravis (MG)

8 registered clinical trials studyying Myasthenia Gravis (MG) — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Anti NCT07526493	Tongji Hospital	Phase 1
Not Yet Recruiting	The Effectiveness of an ETP Programme in Myasthenia Gravis: a Proof-of-concept Study. NCT07512375	University Hospital, Grenoble	—
Not Yet Recruiting	Talquetamab in Patients With Refractory Generalized Myasthenia Gravis NCT07499323	First Affiliated Hospital of Chongqing Medical University	N/A
Recruiting	Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases NCT07470151	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	N/A
Not Yet Recruiting	Ripertamab for the Treatment of Myasthenia Gravis NCT07372807	Zhongming Qiu	Phase 1 / Phase 2
Recruiting	CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases NCT07337785	Daishi Tian	EARLY_Phase 1
Completed	Long-term Efficacy of Modified Guilu Erxian Glue for Myasthenia Gravis NCT07472777	Beijing University of Chinese Medicine	—
Completed	Efficacy of IVIG Versus PLEX in Myasthenic Crisis in Syria. NCT07532707	Damascus University	N/A